Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Vossloh: Rekorde bei Umsatz und Auftragsbestand, EBIT durch Übernahme belastet (4investors) +++ VOSSLOH Aktie +6,94%

THERMO FISHER Aktie

 >THERMO FISHER Aktienkurs 
441.8 EUR    +0.6%    (TradegateBSX)
Ask: 441.7 EUR / 13 Stück
Bid: 438.5 EUR / 13 Stück
Tagesumsatz: 35 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>THERMO FISHER Performance
1 Woche: -1,8%
1 Monat: +7,8%
3 Monate: -18,7%
6 Monate: -9,3%
1 Jahr: +16,9%
laufendes Jahr: -10,6%
>THERMO FISHER Aktie
Name:  THERMO FISHER SCIENTIFIC
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US8835561023 / 857209
Symbol/ Ticker:  TN8 (Frankfurt) / TMO (NYSE)
Kürzel:  FRA:TN8, ETR:TN8, TN8:GR, NYSE:TMO
Index:  S&P500
Webseite:  https://www.thermofisher...
Profil:  Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents. The company operates through four main segments: analytical technologies, which focuses on advanc..
>Volltext..
Marktkapitalisierung:  166529.18 Mio. EUR
Unternehmenswert:  192920.47 Mio. EUR
Umsatz:  37957.15 Mio. EUR
EBITDA:  9519.1 Mio. EUR
Nettogewinn:  5711.97 Mio. EUR
Gewinn je Aktie:  15.13 EUR
Schulden:  34804.28 Mio. EUR
Liquide Mittel:  8397.15 Mio. EUR
Operativer Cashflow:  6660.14 Mio. EUR
Bargeldquote:  0.67
Umsatzwachstum:  -8.41%
Gewinnwachstum:  -6.71%
Dividende je Aktie:  1.51 EUR
Dividendenrendite:  0.33%
Dividendenschätzung:  0.36%
Div. Historie:  13.03.26 - 0.409417€
15.12.25 - 0.365586€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  THERMO FISHER
Letzte Datenerhebung:  23.04.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 371.62 Mio. St.
Frei handelbar: 99.83%
Rückkaufquote: 1.53%
Mitarbeiter: 125000
Umsatz/Mitarb.: 0.3 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 23.42%
Bewertung:
KGV: 29.6
KGV lG: 21.36
KUV: 4.43
KBV: 3.7
PEG-Ratio: 4.02
EV/EBITDA: 20.27
Rentabilität:
Bruttomarge: 40.25%
Gewinnmarge: 15.05%
Operative Marge: 18.84%
Managementeffizenz:
Gesamtkaprendite: 6.46%
Eigenkaprendite: 13.02%
 >Anleihen 
>Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
22.04.26 - 22:00
Thermo Fisher (TMO) Q4 2024 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
22.04.26 - 18:00
Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation (PR Newswire)
 
NEWARK, Del., April 22, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global Cloud Electronic Laboratory Notebook (ELN) Service market is entering a strong growth phase, driven by accelerating digital transformation in research environments, rising......
22.04.26 - 16:12
Thermo Fisher Scientific Q1 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.04.26 - 16:45
Unlocking Q1 Potential of Thermo Fisher (TMO): Exploring Wall Street Estimates for Key Metrics (Zacks)
 
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight....
16.04.26 - 17:30
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy? (Zacks)
 
Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
16.04.26 - 16:45
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results? (Zacks)
 
Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results....
13.04.26 - 19:45
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
10.04.26 - 17:30
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE (Zacks)
 
TMO teams up with PRECISE on a major proteomics study, expanding its role in large biobank projects and precision medicine initiatives....
09.04.26 - 14:09
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort (Benzinga)
 
Seer Proteograph platform joins Singapore study to profile 10,000 samples, integrating data for disease research and risk modeling. Importance Rank:  1 read more...
07.04.26 - 22:36
This Medical Device Stock Has Compounded at 13% Per Year for a Decade (Fool)
 
Thermo Fisher Scientific has outpaced the medical device sector over the past decade....
07.04.26 - 16:00
TMO Stock May Benefit From New Gibco CTS Portfolio Addition (Zacks)
 
Thermo Fisher unveils the Gibco CTS Compleo system to automate cell therapy manufacturing, targeting efficiency gains and consistency as demand in the fast-growing market rises....
02.04.26 - 15:15
TMO Stock May Gain From the Rollout of Gibco CHOvantage GS CLD Kit (Zacks)
 
Thermo Fisher may gain as it unveils its Gibco CHOvantage GS CLD Kit to speed biologics development, cut costs and boost cell culture growth....
01.04.26 - 14:03
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 (Business Wire)
 
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofisher.com. You can access the conference call by dialing (833) 470-1428 within the U.S. or +1 (646) 844-6383 outside the U.S. The access code is 723173. The earnings press release and related information can also be found in that section of our website, under the heading “Financials”. A replay of the call will be available under “News, Events & Presentations” through Wednesday, July 22, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual rev...
27.03.26 - 11:18
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
26.03.26 - 19:06
Patterson Announces Chief Digital Officer (Business Wire)
 
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies has announced the appointment of Gregg Kunes as Patterson's new chief digital officer. Kunes brings a wealth of experience in driving growth and modernization in complex global distribution and manufacturing environments. Kunes will report to Chief Executive Officer Robert Rajalingam, and will lead Patterson's overall digital strategy. Kunes comes to Patterson with over 20 years of experience and most recently was the head of global digital commerce at Thermo Fisher Scientific, where he led digital channel building and optimization efforts across 12 business units and executed the largest global software transformation in the industry. Kunes also served as a division leader at Amazon, leading a digital games and software portfolio he built from the ground up. “We are thrilled to have Gregg join the team at Patterson. Gregg's previous success in delivering innovative and scalable solutions made him the right fit for the role,” said Robert Rajalin...
24.03.26 - 13:06
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. (Business Wire)
 
Further strengthens Thermo Fisher's position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attractive return profile given high growth and strong margin profile of Clario, and meaningful synergies – reflecting the company's disciplined approach to capital deploymentWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the completion of its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, plus potential additional earnout and other payments, largely dependent on performance. With the transaction complete, the Clario business will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. Clario's industry-leading solutions are highly complementary to Thermo Fisher's clinical research offerings, enabling customers to gain critical insights from patient data to improve deci...
20.03.26 - 12:54
EU genehmigt milliardenschwere Übernahme von Clario durch Thermo Fisher (Dow Jones)
 
Von Edith Hancock DOW JONES--Die Europäische Kommission hat die Übernahme des US-Medizintechnologie-Anbieters Clario Holdings durch das US-Unternehmen Thermo Fisher Scientific ......
13.03.26 - 00:06
XETR: DIVIDEND/INTEREST INFORMATION - 13.03.2026 - US8835561023 (XETRA)
 
Das Instrument TN8 US8835561023 THERMO FISH.SCIENTIF.DL 1 EQUITY wird ex Dividende/Zinsen gehandelt am 13.03.2026 The instrument TN8 US8835561023 THERMO FISH.SCIENTIF.DL 1 EQUITY has its ex-dividend/interest day on 13.03.2026...
12.03.26 - 23:01
Insiderhandel: Executive Vice President verkauft Aktien von Thermo Fisher Scientific im Wert von 802536 USD (Insiderkauf)
 
Shafer, Michael D. - Vorstand - Tag der Transaktion: 2026-03-11...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Quod cito fit, cito perit - Was schnell entsteht, auch schnell vergeht. - Nomen Nescio
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!